Is BYD a Threat To Tesla Shareholders?
BYD (OTC:BYDDY) has rocketed to the top of China’s booming…
Sell
48
INNV Quote, Financials, Valuation and Earnings
Last price:
$3.40
Seasonality move
:
12.33%
Day range:
$2.85 - $3.31
52-week range:
$2.60 - $6.69
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.55x
P/B ratio:
1.77x
Volume:
79.5K
Avg. volume:
40.7K
1-year change:
-23.47%
Market cap:
$440.9M
Revenue:
$763.9M
EPS (TTM):
-$0.20
Analysts' Opinion
-
Consensus RatingInnovAge Holding has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $5.00, InnovAge Holding has an estimated upside of 53.37% from its current price of $3.26.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $5.00 representing -53.37% downside risk from its current price of $3.26.
Fair Value
-
According to the consensus of 3 analysts, InnovAge Holding has 53.37% upside to fair value with a price target of $5.00 per share.
INNV vs. S&P 500
-
Over the past 5 trading days, InnovAge Holding has overperformed the S&P 500 by 5.18% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
InnovAge Holding does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
InnovAge Holding has grown year-over-year revenues for 7 quarters straight. In the most recent quarter InnovAge Holding reported revenues of $209M.
Earnings Growth
-
InnovAge Holding earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter InnovAge Holding reported earnings per share of -$0.10.
Enterprise value:
447.1M
EV / Invested capital:
--
Price / LTM sales:
0.55x
EV / EBIT:
--
EV / Revenue:
0.55x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-166.71x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
61.20x
Gross Profit (TTM):
$142.2M
Return On Assets:
-4.84%
Net Income Margin (TTM):
-3.19%
Return On Equity:
-8.76%
Return On Invested Capital:
-7.17%
Operating Margin:
-1.94%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $688.9M | $720.8M | $806.6M | $188.9M | $209M | |
| Gross Profit | $95.6M | $118.8M | $142.2M | $33.6M | $37.1M | |
| Operating Income | -$49.3M | -$31.6M | -$19.6M | -$1.8M | -$4.1M | |
| EBITDA | -$34.2M | -$15.5M | -$567K | $1.5M | -$7.4M | |
| Diluted EPS | -$0.28 | -$0.24 | -$0.20 | -$0.03 | -$0.10 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $123.1M | $265.9M | $199.5M | $157M | $168M | |
| Total Assets | $374.7M | $558M | $546.1M | $534.3M | $524.8M | |
| Current Liabilities | $92.5M | $89.3M | $106.2M | $123.1M | $145M | |
| Total Liabilities | $406M | $189.6M | $214.3M | $231.3M | $246.8M | |
| Total Equity | -$31.3M | $368.4M | $331.8M | $303M | $278M | |
| Total Debt | $293.1M | $73.7M | $70.3M | $67M | $63.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$26.3M | -$53K | $4.6M | -$9.3M | $6.8M | |
| Cash From Investing | -$86.2M | -$36.1M | $1.5M | -$23.1M | $4.4M | |
| Cash From Financing | -$6.6M | -$9.2M | -$14.1M | -$1.9M | -$4.1M | |
| Free Cash Flow | -$67.5M | -$12.9M | -$2.7M | -$10.9M | $5.4M | |
INNV
Sector
Market Cap
$440.9M
$34.5M
Price % of 52-Week High
48.73%
43.57%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.79%
1-Year Price Total Return
-23.47%
-42.08%
Beta (5-Year)
--
0.660
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$3.05
200-day SMA
Sell
Level
$4.62
Bollinger Bands (100)
Sell
Level
2.95 - 3.93
Chaikin Money Flow
Buy
Level
9.1M
20-day SMA
Buy
Level
$2.93
Relative Strength Index (RSI14)
Buy
Level
58.04
ADX Line
Buy
Level
19.06
Williams %R
Sell
Level
-13.1579
50-day SMA
Buy
Level
$3.07
MACD (12, 26)
Buy
Level
0.01
25-day Aroon Oscillator
Buy
Level
20
On Balance Volume
Sell
Level
-11M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.823)
Buy
CA Score
(Annual)
Level (-0.0374)
Sell
Beneish M-Score
(Annual)
Level (-1.5487)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (1.1809)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.
Stock Forecast FAQ
In the current month, INNV has received 0 Buy ratings 3 Hold ratings, and 0 Sell ratings. The INNV average analyst price target in the past 3 months is $5.00.
-
Where Will InnovAge Holding Stock Be In 1 Year?
According to analysts, the consensus estimate is that InnovAge Holding share price will rise to $5.00 per share over the next 12 months.
-
What Do Analysts Say About InnovAge Holding?
Analysts are divided on their view about InnovAge Holding share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that InnovAge Holding is a Sell and believe this share price will drop from its current level to $5.00.
-
What Is InnovAge Holding's Price Target?
The price target for InnovAge Holding over the next 1-year time period is forecast to be $5.00 according to 3 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is INNV A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for InnovAge Holding is a Hold. 3 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of INNV?
You can purchase shares of InnovAge Holding via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase InnovAge Holding shares.
-
What Is The InnovAge Holding Share Price Today?
InnovAge Holding was last trading at $3.40 per share. This represents the most recent stock quote for InnovAge Holding. Yesterday, InnovAge Holding closed at $3.26 per share.
-
How To Buy InnovAge Holding Stock Online?
In order to purchase InnovAge Holding stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 8
Regencell Bioscience Holdings [RGC] is up 12.11% over the past day.
Buy
92
TPB alert for May 8
Turning Point Brands [TPB] is down 6.96% over the past day.
Buy
74
LIVN alert for May 8
LivaNova PLC [LIVN] is up 1.06% over the past day.
